Page last updated: 2024-10-28

haloperidol and Adiadochokinesis

haloperidol has been researched along with Adiadochokinesis in 2 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ranjan, S1
Jagadheesan, K1
Nizamie, SH1
Browne, JL1
Hart, RR1

Other Studies

2 other studies available for haloperidol and Adiadochokinesis

ArticleYear
Cerebellar ataxia with intravenous valproate and haloperidol.
    The Australian and New Zealand journal of psychiatry, 2002, Volume: 36, Issue:2

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cerebellar Ataxia; Haloperidol; Hum

2002
Exacerbation of tardive dyskinesia by Joseph disease.
    The Journal of clinical psychiatry, 1986, Volume: 47, Issue:6

    Topics: Aged; Brain Diseases; Cerebellar Ataxia; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Ment

1986